Thyroid C-cell hyperplasia shown by combined In-111 pentetreotide, Tc-99m pertechnetate, and Tc-99m MIBI scintigraphy.
Cecchin
Diego
D
Nuclear Medicine Unit, Department of Diagnostic Medical Sciences, Padua University Hospital, Italy. diego.cecchin@unipd.it
Lumachi
Franco
F
Marino
Filippo
F
Stramare
Roberto
R
Basso
Umberto
U
Grassetto
Gaia
G
Bui
Franco
F
D000236:Adenoma / Q000473:pathology; D049109:Cell Proliferation; D015179:Colorectal Neoplasms / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D006965:Hyperplasia; D007205:Indium Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013670:Sodium Pertechnetate Tc 99m / Q000494:pharmacology*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000494:pharmacology; D017256:Technetium Tc 99m Sestamibi / Q000494:pharmacology*; D013961:Thyroid Gland / Q000473:pathology*; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000556:secondary; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
D007205:Indium Radioisotopes; D013004:Somatostatin; D017256:Technetium Tc 99m Sestamibi; D013670:Sodium Pertechnetate Tc 99m; C081788:pentetreotide